UnitedHealth to buy LHC Group for $5.4 billion in home healthcare push
Reuters
Published Mar 29, 2022 07:16AM ET
Updated Mar 29, 2022 08:51AM ET
(Reuters) -UnitedHealth Group said on Tuesday it would buy LHC Group (NASDAQ:LHCG) for about $5.4 billion in cash, as the largest U.S. health insurer expands its home health services.
The deal will combine the provider of healthcare services at home, mainly for older patients dealing with chronic illness and injuries, with UnitedHealth (NYSE:UNH)'s Optum unit, which manages drug benefits and offers healthcare data analytics services.
Demand for home healthcare over clinic-based services has increased in the United States, especially during the COVID-19 pandemic as patients and caregivers increasingly prefer to access vital services from the safety of their homes.
The deal comes a month after the U.S. Justice Department sued to stop UnitedHealth's $8 billion acquisition of billing and payment services provider Change Healthcare (NASDAQ:CHNG), saying the deal would give the health insurer access to its competitors' data.
UnitedHealth will pay $170 for each share of LHC Group, representing an 8.12% premium to the stock's last close.
Shares of LHC climbed 7.5% and were trading just shy of the offer at $168.70 before the opening bell, while those of UNH rose marginally.
UnitedHealth expects the LHC deal to be neutral to its outlook for adjusted profit per share in 2022 and modestly add in 2023. LHC Group co-founders Keith and Ginger Myers will invest $10 million in the health insurer's stock, following the close of the deal.
Last year, health insurer Humana (NYSE:HUM) acquired the remaining 60% stake it did not own in home health provider Kindred at Home for $5.7 billion to expand its patient care business.
SVB Leerink and Jefferies LLC served as financial advisers to LHC Group.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.